[Double blind study of the efficacy and safety of the fixed dose combination of enalapril 10 mg/nitrendipine 20 mg versus the increase of amlopidine dose in essential hypertensive patients not controlled with amlodipine 5 mg].
In: Revista clinica espanola, Jg. 205 (2005-09-01), Heft 9, S. 418-24
academicJournal
Zugriff:
Introduction: Combined therapy or dose-tiration are acceptable second-line therapeutic options after a first treatment failure.
Material and Methods: This double blind clinical trial compared the fixed dose combination of enalapril 10 mg/nitrendipine 20 mg (E/N) with amlopidine 10 mg (A) in 323 hypertensive patients not previously controlled with amlodipine 5 mg.
Results: After 6 weeks of treatment, the E/N and A groups had similar percentages of blood pressure normalization (55% versus 60.2%; p = 0.4588). The adverse events related with the treatment were significantly less frequent with E/N than with a (19.8% versus 37%; p = 0.0029), especially due to a lower incidence of malleolar edema in E/N (11.1% versus 33.6%; p < 0.0001).
Conclusion: Combining the efficacy and tolerability data, treatment with E/N permitted control of blood pressure of 2.8 patients per every patient with adverse events, while this rate for A was 1.6 to 1.
Titel: |
[Double blind study of the efficacy and safety of the fixed dose combination of enalapril 10 mg/nitrendipine 20 mg versus the increase of amlopidine dose in essential hypertensive patients not controlled with amlodipine 5 mg].
|
---|---|
Autor/in / Beteiligte Person: | Marín-Iranzo, R ; de la Sierra-Iserte A ; Roca-Cusachs, A ; Oliván-Martínez, J ; Redón-Mas, J ; Luque-Otero, M ; de la Figuera-von Wichman M ; Pontes-García, C ; Delgadillo-Duarte, J |
Zeitschrift: | Revista clinica espanola, Jg. 205 (2005-09-01), Heft 9, S. 418-24 |
Veröffentlichung: | 2010- : Madrid : Elsevier España ; <i>Original Publication</i>: Barcelona : Doyma, 2005 |
Medientyp: | academicJournal |
ISSN: | 0014-2565 (print) |
DOI: | 10.1157/13079069 |
Schlagwort: |
|
Sonstiges: |
|